Following Positive Epidemiologic Studies, Statins to Enter Clinical Trials for Cancer Prevention von Zielinski, Sarah L

Volltext

FDA Attempting To Overcome Major Roadblocks in Monitoring Drug Safety von Zielinski, Sarah L

Volltext

Hormone Replacement Therapy for Breast Cancer Survivors: An Answered Question? von Zielinski, Sarah L

Volltext

Neuroblastoma Screening Showed Early Detection Doesn't Always Save Lives von Zielinski, Sarah L.

Volltext

Diversity in Cancer Rates, Control Programs Matches Diversity of European Union von Zielinski, Sarah L

Volltext

As Genetic Tests Move Into the Mainstream, Challenges Await for Doctors and Patients von Zielinski, Sarah L

Volltext

Despite Positive Studies, Popularity of Chemoprevention Drugs Increasing Slowly von Zielinski, Sarah L

Volltext

Trial Quickly Changed Management of Cervical Abnormalities von Zielinski, Sarah L

Volltext

Smoking Machine Test Inadequate and Confusing, But No Replacement a Decade Later von Zielinski, Sarah L

Volltext

Clinical Trials Registration Efforts Gain Some Ground von Zielinski, Sarah L

Volltext

2005 Medicare payments for chemotherapy will exceed costs von Zielinski, Sarah L

Volltext

NIH Clarifies New Model Organisms Sharing Policy von Zielinski, Sarah L

Volltext

Last Decade Brought New Guidelines, Detection Methods for Colon Cancer Screening von Zielinski, Sarah L

Volltext

Money Matters: How Cost-Effectiveness Studies Are Done von Zielinski, Sarah L

Volltext

BRCA1 Discovery Led to Patent Debate, Genetic Screening von Zielinski, Sarah L

Volltext

After 10 Years, No Clear Answers About Breast Cancer on Long Island von Zielinski, S. L.

Volltext

Project Creates Repository for Microarray Datasets von Zielinski, Sarah L

Volltext

In Brief von Zielinski, Sarah L

Volltext

In Brief von Zielinski, Sarah L.

Volltext

In Brief von Zielinski, Sarah L.

Volltext